Stockscreener 앱 받기
83.48
0.06%
-0.0536
Crinetics Pharmaceuticals Inc 주식(CRNX)의 최신 뉴스
Vertex to acquire Crinetics in deal worth around $10.0bn - PMLiVE
Vertex carries M&A uptick into H2, IPOs and VC raises also grow, FDA on pace despite turmoil - BioSpace
Viking Therapeutics (VKTX) Draws Takeover Focus After Vertex's $10 Billion Crinetics Deal - Yahoo Finance
Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It. - The Globe and Mail
Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It. - The Motley Fool
The $10B Integration Problem Vertex Hasn’t Solved Yet - The Clinical Trial Vanguard
Narrow-Moat Vertex's Strong CF Cash Flows Support Expansion Into Endocrinology Via Crinetics - Morningstar
Vertex Is Buying Crinetics for $10 Billion. Here's What Investors Need to Know. - The Motley Fool
Why Did CRNX, D, BCRX Stocks Surge To 52-Week Highs Today? - Yahoo Finance
Why Crinetics Stock Doubled After Vertex’s $10 Billion Buyout - BeInCrypto
Vertex to acquire Crinetics in $10 billion rare-disease push - MSN
Investigation launched into Crinetics Pharma bo... - Pluang
Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms - The Boston Globe
Crinetics Pharmaceuticals director sells $120,000 in stock - Investing.com
Vertex Pharma’s Growth Strategy Leads to Its Biggest-Ever M&A Deal - MedCity News
Form 4 Crinetics Pharmaceuticals Inc For: 7 July By Investing.com - Investing.com India
Vertex Eyes Expansion Beyond Cystic Fibrosis with Planned $10B Crinetics Buyout - Genetic Engineering and Biotechnology News
Crinetics Pharmaceuticals director sells $120,000 in stock By Investing.com - Investing.com Canada
Crinetics (CRNX) director sells 3,000 shares at $40 in planned trade - Stock Titan
Vertex (VRTX) Is Buying Crinetics For $10 Billion And Entering Endocrinology - Yahoo Finance
Eli Lilly price target boost, Vertex-Crinetics deal, Meta's new social media lawsuit - Yahoo Finance
The Changing Reality of Pharmaceutical Commercialization | PharmExec - Pharmaceutical Executive
Vertex to buy Crinetics in an all-cash deal valued at $10 billion - CNBC
Vertex Pays $10 Billion to Enter Rare Endocrine Disease - TradingView
Vertex's $10B Crinetics deal marks its clearest step yet toward biopharma's top ranks - Endpoints News
This Biotech Stock Is Soaring 99% After Vertex Agrees to Takeover Deal - Barron's
Vertex to Acquire Crinetics Pharmaceuticals for $10 Billion - Pharmaceutical Executive
CRNX Soars On $10B Vertex Buyout As Trading Dynamics Shift - StocksToTrade
CRNX Downgraded by Jones Trading -- Rating Changed to Hold - GuruFocus
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Crinetics Pharmaceuticals Cut to Hold From Buy by Jones Trading - Moomoo
Crinetics Pharmaceuticals (CRNX) Agreed To A $10 Billion All Cash Sale To Vertex - simplywall.st
CRNX Soars On Vertex’s $10B Buyout And Tight Trading Range - StocksToTrade
Endocrinology becomes Vertex’s fifth pillar with $10B Crinetics buy - BioWorld News
SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout | Stock Movers - marketscreener.com
Compass says depression drug has long-lasting benefits - STAT
Crinetics (CRNX) Soars 98.8% to Reach $83.55 - GuruFocus
CRNX Downgraded by Oppenheimer -- Rating Changed to Perform - GuruFocus
Vertex Pharmaceuticals (VRTX) Announces Strategic Merger with Cr - GuruFocus
Vertex makes largest ever acquisition with $10bn Crinetics deal - BioXconomy
Crinetics Pharmaceuticals stock hits all-time high at 83.59 USD By Investing.com - Investing.com Nigeria
Jones Trading downgrades Crinetics stock rating on Vertex acquisition - Investing.com
Crinetics Pharmaceuticals stock hits all-time high at 83.59 USD - Investing.com
Vertex Pharmaceuticals to acquire Crinetics in a $10 billion deal, sending the latter's share price nearly doubling - 富途牛牛
Crinetics shares surge after Vertex agrees to $10B cash buyout - Invezz
Crinetics Pharmaceuticals Stock (CRNX) Opinions on Vertex Acquisition - Quiver Quantitative
CRNX Stock Soars On $10B Vertex Takeover Deal - StocksToTrade
Crinetics Acquisition Creates A ‘Fifth Commercial Pillar’ For Vertex, Says Analyst – Why HC Wainwright Sees A 24% Upside Potential In VRTX Stock - Yahoo Finance
Vertex Pharmaceuticals buying Crinetics for $10 billion - qz.com
CRINETICS PHARMACEUTICALS, INC. (CRNX) - MSN
Crinetics (CRNX) Stock Surges Ahead of Vertex's $10 Billion Acqu - GuruFocus
Dow Gains Over 200 Points; US Trade Deficit Widens In MayCrinetics Pharmaceuticals (NASDAQ:CRNX), Digi - Benzinga
Crinetics stocks surge after Vertex agrees to $10B cash buyout - Invezz
Cantor Sees 'Clear Strategic Rationale' Behind Vertex's Buy of Crinetics -- Market Talk - Moomoo
Vertex Doesn't Need Crinetics Deal to Generate $5 Billion to Be Success, Evercore Says -- Market Talk - Moomoo
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Crinetics Pharmaceuticals, Inc. (CRNX) - TMX Newsfile
VRTX to Strengthen Rare Disease Portfolio With $10B Crinetics Buyout - Yahoo Finance
Crinetics Pharmaceuticals Acquired by Fortress Biotech for $10 B - GuruFocus
Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and more - STAT
Vertex To Acquire Crinetics For ~$10bnWhat Investors Should Know (NASDAQ:CRNX) - Seeking Alpha
Cantor Fitzgerald reiterates Vertex stock rating on Crinetics deal By Investing.com - Investing.com Nigeria
Vertex to Acquire Crinetics Pharmaceuticals for $85 a share - MLex
1.01%
5.65%
자본화:
|
볼륨(24시간):